$2.36 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 64 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 31.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | Buy | BIOGEN IDEC INC | $177,008,000 | +7.9% | 561,379 | +4.7% | 7.50% | +11.1% |
| AMGN | Sell | AMGEN INC | $141,472,000 | -18.4% | 1,195,165 | -14.9% | 5.99% | -15.9% |
| GILD | Sell | GILEAD SCIENCES INC | $124,292,000 | -14.7% | 1,499,116 | -27.1% | 5.27% | -12.2% |
| CELG | Buy | CELGENE CORP | $107,408,000 | +35.9% | 1,250,672 | +120.9% | 4.55% | +39.9% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $102,204,000 | +13.2% | 1,079,464 | -15.5% | 4.33% | +16.6% |
| INCY | Buy | INCYTE CORPORATION | $88,693,000 | +18.1% | 1,571,452 | +12.0% | 3.76% | +21.7% |
| TEVA | Buy | TEVA PHARMACEUTICALadr | $79,290,000 | +4.1% | 1,512,587 | +4.9% | 3.36% | +7.2% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $76,423,000 | -8.3% | 489,108 | -10.7% | 3.24% | -5.6% |
| MYL | Buy | MYLAN INC | $76,308,000 | +12.4% | 1,479,982 | +6.4% | 3.23% | +15.8% |
| B108PS | Buy | ACTAVIS PLCshares | $75,714,000 | +25.1% | 339,450 | +15.5% | 3.21% | +28.9% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $72,693,000 | +14.9% | 1,168,504 | +26.0% | 3.08% | +18.4% |
| REGN | Sell | REGENERON PHARMCTCLS | $64,375,000 | -30.3% | 227,900 | -25.9% | 2.73% | -28.2% |
| KERX | Buy | KERYX BIOPHARMACEUTICALS INC | $57,547,000 | -4.5% | 3,741,656 | +5.8% | 2.44% | -1.7% |
| SHPG | Sell | SHIRE PLCsp adr | $54,312,000 | -6.5% | 230,636 | -41.0% | 2.30% | -3.7% |
| GEVA | Buy | SYNAGEVA BIOPHARMA | $54,123,000 | +40.2% | 516,445 | +11.0% | 2.29% | +44.5% |
| P103PS | Buy | NPS PHARMACEUTICALS | $52,222,000 | +23.9% | 1,580,094 | +12.2% | 2.21% | +27.6% |
| TMO | Sell | THERMO FISHER SCIENTIFIC | $51,955,000 | -45.0% | 440,300 | -43.9% | 2.20% | -43.3% |
| THRX | Sell | THERAVANCE INC | $51,912,000 | -9.4% | 1,743,188 | -5.8% | 2.20% | -6.6% |
| PRGO | New | PERRIGO COshares | $51,215,000 | – | 351,368 | +100.0% | 2.17% | – |
| ILMN | Buy | ILLUMINA INC | $44,062,000 | +21.0% | 246,789 | +0.7% | 1.87% | +24.6% |
| HALO | Sell | HALOZYME THERAPEUTICS | $43,370,000 | -36.3% | 4,389,682 | -18.0% | 1.84% | -34.3% |
| PTCT | Buy | PTC THERAPEUTICS INC | $40,550,000 | +63.7% | 1,551,274 | +63.7% | 1.72% | +68.6% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS | $39,835,000 | +26.9% | 1,365,152 | +12.6% | 1.69% | +30.8% |
| INSM | Buy | INSMED INC | $39,675,000 | +77.8% | 1,985,738 | +69.4% | 1.68% | +83.1% |
| MNKKQ | Buy | MALLINCKRODT PLCshares | $38,535,000 | +34.2% | 481,564 | +6.4% | 1.63% | +38.3% |
| IMGN | Sell | IMMUNOGEN INC | $38,137,000 | -29.5% | 3,218,276 | -11.2% | 1.62% | -27.4% |
| MRK | Sell | MERCK & CO INC | $37,868,000 | -0.1% | 654,582 | -1.9% | 1.60% | +3.0% |
| AGN | Sell | ALLERGAN INC | $32,499,000 | -47.3% | 192,050 | -61.3% | 1.38% | -45.7% |
| OMED | Buy | ONCOMED PHARMACEUTICALS | $32,445,000 | -28.5% | 1,392,485 | +3.3% | 1.38% | -26.3% |
| SGNT | Buy | SAGENT PHARMACEUTICALS | $27,394,000 | +12.9% | 1,059,306 | +2.0% | 1.16% | +16.3% |
| AKRXQ | Sell | AKORN INC | $25,258,000 | +50.8% | 759,643 | -0.2% | 1.07% | +55.3% |
| SGEN | Buy | SEATTLE GENETICS INC | $23,417,000 | +16.1% | 612,219 | +38.3% | 0.99% | +19.5% |
| RDY | Buy | DR REDDYS LABS LTDadr | $22,003,000 | +16.1% | 509,917 | +18.1% | 0.93% | +19.6% |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $21,302,000 | +25.5% | 168,900 | +31.1% | 0.90% | +29.4% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $20,224,000 | +56.3% | 1,674,140 | +50.7% | 0.86% | +61.1% |
| XLRN | New | ACCELERON PHARMA | $20,010,000 | – | 589,053 | +100.0% | 0.85% | – |
| F113PS | Buy | COVIDIEN PLCshares | $19,697,000 | +27.4% | 218,422 | +4.1% | 0.84% | +31.3% |
| ICPT | Sell | INTERCEPT PHARMACEUTICALS | $17,509,000 | -28.7% | 73,993 | -0.7% | 0.74% | -26.6% |
| RLYP | New | RELYPSA INC | $17,340,000 | – | 712,973 | +100.0% | 0.74% | – |
| ALGN | Buy | ALIGN TECH INC | $16,496,000 | +61.6% | 294,356 | +49.4% | 0.70% | +66.4% |
| UTHR | Sell | UNITED THERAPEUTICS | $16,141,000 | -26.8% | 182,400 | -22.2% | 0.68% | -24.6% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $16,053,000 | +13.1% | 38,983 | +20.3% | 0.68% | +16.4% |
| ABBV | Sell | ABBVIE INC | $15,337,000 | +8.9% | 271,741 | -0.8% | 0.65% | +12.3% |
| CMRX | New | CHIMERIX INC | $13,864,000 | – | 631,894 | +100.0% | 0.59% | – |
| BSX | Buy | BOSTON SCIENTIFIC | $13,327,000 | -3.3% | 1,043,587 | +2.4% | 0.56% | -0.4% |
| CLVS | Sell | CLOVIS ONCOLOGY | $13,042,000 | -61.8% | 314,952 | -36.2% | 0.55% | -60.7% |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $12,501,000 | – | 268,540 | +100.0% | 0.53% | – |
| DXCM | Buy | DEXCOM INC | $11,401,000 | +286.3% | 287,471 | +302.9% | 0.48% | +299.2% |
| TRNX | Buy | TORNIER N V | $11,172,000 | +18.9% | 477,829 | +7.9% | 0.47% | +22.5% |
| HTWR | Buy | HEARTWARE INTL INC | $10,720,000 | +15.2% | 121,127 | +22.1% | 0.45% | +18.5% |
| CI | New | CIGNA CORP | $7,802,000 | – | 84,832 | +100.0% | 0.33% | – |
| NXTM | Sell | NXSTAGE MEDICAL | $7,121,000 | +12.6% | 495,556 | -0.2% | 0.30% | +16.2% |
| INGN | Sell | INOGEN INC | $6,344,000 | +35.6% | 281,200 | -0.8% | 0.27% | +40.1% |
| NVO | Sell | NOVO-NORDISK ASadr | $5,982,000 | -4.1% | 129,510 | -5.2% | 0.25% | -1.6% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $5,530,000 | -90.3% | 360,724 | -92.2% | 0.23% | -90.1% |
| TBPH | New | THERAVANCE BIOPHARMA | $4,851,000 | – | 152,151 | +100.0% | 0.21% | – |
| ARAY | Buy | ACCURAY INC | $4,325,000 | -6.9% | 491,505 | +1.6% | 0.18% | -4.2% |
| NVS | Buy | NOVARTIS AGsp adr | $3,141,000 | +18.4% | 34,700 | +11.2% | 0.13% | +22.0% |
| RNA | New | PROSENSA HLDGS | $957,000 | – | 75,834 | +100.0% | 0.04% | – |
| TNDM | Buy | TANDEM DIABETES CA | $898,000 | +35.0% | 55,231 | +83.5% | 0.04% | +40.7% |
| ALDR | New | ALDER BIOPHARMACEUTICALS | $813,000 | – | 40,525 | +100.0% | 0.03% | – |
| MDVN | New | MEDIVATION INC | $789,000 | – | 10,233 | +100.0% | 0.03% | – |
| ANTH | Sell | ANTHERA PHARMACEUTICALS | $744,000 | +0.3% | 219,609 | -0.8% | 0.03% | +3.2% |
| WX | Buy | WUXI PHARMATECHsp adr | $434,000 | +75.7% | 13,193 | +97.2% | 0.02% | +80.0% |
| AQXP | Exit | AQUINOX PHARMACEUT | $0 | – | -30,000 | -100.0% | -0.02% | – |
| TKMR | Exit | TEKMIRA PHARMACEU | $0 | – | -27,500 | -100.0% | -0.02% | – |
| LPTN | Exit | LPATH INC | $0 | – | -126,464 | -100.0% | -0.02% | – |
| FPRX | Exit | FIVE PRIME THERAPE | $0 | – | -32,372 | -100.0% | -0.03% | – |
| GLYC | Exit | GLYCOMIMETICS INC | $0 | – | -44,587 | -100.0% | -0.03% | – |
| EBIO | Exit | ELEVEN BIOTHERAPEU | $0 | – | -50,000 | -100.0% | -0.03% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS | $0 | – | -1,408,908 | -100.0% | -1.02% | – |
| FRX | Exit | FOREST LABS INC | $0 | – | -270,100 | -100.0% | -1.02% | – |
| ISIS | Exit | ISIS PHARMACEUTICALS | $0 | – | -882,101 | -100.0% | -1.57% | – |
| AEGR | Exit | AEGERION PHARMACEU | $0 | – | -934,100 | -100.0% | -1.77% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.